Back
Stoke Therapeutics Vs. NeuBase Therapeutics Industry Stock Comparison
Buy
72
STOK
Stoke Therapeutics
Last Price:
15.37
Seasonality Move:
-14.01%
Sell
21
NBSE
NeuBase Therapeutics
Last Price:
0.38
Seasonality Move:
5.89%
Buy
72
Stoke Therapeutics (STOK)
is a Buy
Is Stoke Therapeutics a Buy, Sell or Hold?
- The current Stoke Therapeutics [STOK] share price is $16.10. The Score for STOK is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- STOK is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
21
NeuBase Therapeutics (NBSE)
is a Sell
Is NeuBase Therapeutics a Buy, Sell or Hold?
- The current NeuBase Therapeutics [NBSE] share price is $0.38. The Score for NBSE is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- NBSE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
STOK Stock Price Chart
What is Stoke Therapeutics's stock price today?
-
The Stoke Therapeutics share price today is $16.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBSE Stock Price Chart
What is NeuBase Therapeutics's stock price today?
-
The NeuBase Therapeutics share price today is $0.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBSE is experiencing slight buying pressure.
STOK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 74.54 | Buy |
| Chaikin Money Flow: | 969548 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.09 - 13.37) | Buy |
| Bollinger Bands (100): | (4.88 - 11.78) | Buy |
NBSE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 30.84 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.39 - 0.43) | Sell |
| Bollinger Bands (100): | (0.43 - 0.83) | Sell |
STOK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.25 | Buy |
| 20-day SMA: | 12.33 | Buy |
| 50-day SMA: | 11.1 | Buy |
| 200-day SMA: | 6.47 | Buy |
| 8-day EMA: | 13.72 | Buy |
| 20-day EMA: | 12.7 | Buy |
| 50-day EMA: | 11.15 | Buy |
| 200-day EMA: | 8.34 | Buy |
NBSE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.38 | Sell |
| 20-day SMA: | 0.4 | Sell |
| 50-day SMA: | 0.54 | Sell |
| 200-day SMA: | 0.74 | Sell |
| 8-day EMA: | 0.38 | Sell |
| 20-day EMA: | 0.41 | Sell |
| 50-day EMA: | 0.5 | Sell |
| 200-day EMA: | 1.48 | Sell |
Stoke Therapeutics Earnings Growth & STOK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.35 per share.
NeuBase Therapeutics Earnings Growth & NBSE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.28 per share, and a decrease next year of $0.50 per share.
Stoke Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NeuBase Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||